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INTRODUCTION
Although the differential response of malignant cells
to hyperthermia was observed at the end of the last century,
few investigations into the phenomenon were made until
fairly recently.

At first the results obtained were incon-

sistent due mostly to the inefficient techniques in use at
the time.

The advent of cell and tissue culture, increased

knowledge in tumor biology, advances in molecular biology,
and the development of equipment which could raise and
monitor the :.temperature of tumors during hyperthermic
treatments, have made the study of the effects of supranormal temperature on malignant neoplasias substantially more
reliable.
It has been shown that the use of hyperthermia in conjunction with drugs (Woodall et al. , 1960; Hahn

~.!

al. , 1975)

or radiotherapy (Overgard and Okkels, 1940) enhances, in
some cases, the effects of the treatment in an additive or
synergystic form.

Some of the drugs tested with hyperthermia

were 5-fluoro-2'-deoxyuridine (FUDR), 1-erythro-a,S-dihydroxybutyraldehyde (DI-IBA), actinomycin D, DL-glyceraldehyde and
2 deoxy-D-glucose, sodium oxamate, vinblastine, L-phenyl
alanine mustard (PAM), 2,5-diethylenimino-3, 6-bis(2-methoxyethoxy)-1,4 benzoquinone (A 139);triethylene thiophophoramide (TSPA), triethylene melanine (TEM) and N-3-oxapenta-·

2

methylene-N 1 ,N 1 1 -diethylene thiophosphoramide (OPSPA)
( Giovanella et al. , 1970; Woodhall et al. , 1960).
The effectiveness of the combined treatment of hyperthermia and drugs has been established.

A substantial

amount of research to ascertain the most efficient uses of
combined treatments (or for finding or screening new drugs)
remains to be done.
Historical Review
1.

In Vitro Experiments
Lambert (1912) studied the effect of hyperthermia on

normal connective tissue cells from the aorta and pulmonary
veins of a mouse, and from a transplantable mouse sarcoma.
Using a hanging drop plasma preparation containing actively
proliferating cells, he observed that both types (normal
and malignant) grew best between 37 and 39°C.
and multiplication

o~curred

Cell wandering

at 40 to 410C; temperatures

above 42°C were harmful to the cultures.

Damage was pro-

portional to increase in temperature and to length of
exposure.

Lambert also found that normal connective tissues

survived from 24 to 48 hours after exposure to 42.50C, while
sarcoma cells were destroyed.

Connective tissue cells

retained their viability after a 6-hour exposure at 430C and
20 minutes at 460C,

Sarcoma cells subjected to the same

treatments did not survive.
Selawri et al. (1957) compared the effects of supranormal temperatures on different tumors using three. cell

3

types:

Hela, H. Ep.#2 (from carcinoma of the larynx) and

J 96 (from the peripheral blood of a patient afflicted with

monocytic leukemia).
·cause cell death.

A minimum of

42~C

was required to

The 3 cell lines were found to form

thermotolerant strains when they were incubated at temperatures higher than normal.

These investigators also studied

the effect of hyperthermia on the mitotic cycle of Hela
cells.
Burger and Furman (1964) assessed the damage caused by
supranormal temperatures (40-47.50C) to slices of cerebral
cortex and liver by measuring oxygen consumption, cholesterol and ammonia accumulation and leakage of rubidium 86 .
Ammonia accumulation was found to be the most sensitive
indicator for assessing damage.
Sisken et al. (1965) studied the effect of temperature
on the duration of different phases of the mitotic cycle.
For temperatures above the 37-38°C optimum range they found
tha~

the time throtigh metaphase was increased.

The cells

used in this experiment were from a human amnion cell line.
Auersperg (1966) exposed human fibroblasts, obtained
from a skin biopsy and epithelial cells from carcinoma lines
C4 and C27, to hyperthermia.

He found that· at 44 and 48°C

both cell types responded in a similar way but that at 460C
there was a different response that favored the viability
of the malignant cells.

The difference was most

ma~ked

after a heating period of 30 minutes; at this particular
time the survival was approximately 70% for the carcinoma
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cells but less than 10% for the fibroblasts.
Cavaliere et al. (1967) found that the oxygen uptake
of Novikoff hepatomas and Ehrlich ascites carcinoma cells
was lower at 42°C than at ssoc; this difference was found
to be minimal when the respiration of normal and regenerating
liver cells was measured under the same experimental conditions.
McCormic and Penman (1968) and Palzer and Heildelberger (1973) found that drugs that inhibited RNA synthesis
interfered with the recovery mechanism of cells damaged by
exposure to hyperthermia.

Fuhr (1974) used cycloheximide

and actinomycin D to study the recovery of protein synthesis
in murine leukemic lymphoblasts subjected to heat shock; he
found that actinomycin D and cycloheximide. impaired this
process when added to the cells prior to the treatment.
Actinomycin D also impaired recovery of protein synthesis
when added after exposure to heat.

Recovery was enhanced

when cycloheximide was present prior to and during hyperthermia.

Fuhr also suggested that an RNA required for pro-

tein synthesis is inactivated or destroyed.
The in vitro combined effect of drugs.and hyperthermia
and the potential tise of this modality in the management of
some malignancies has been studied.

Giovanella et al. (1970)

found that the simultaneous treatment of L 1210 leukemia
cells with hyperthermia and DHBA is 100 times more effective
than when each is applied separately.

Hahn et al. (1975)

tested the combined effect of hyperthermia with the antibiotics
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bleomycin and adriamycin (both are currently used in the
treatment of a variety of solid tumors) on Chinese hamster
cells (HAl) and mouse mammary sarcoma cells (EMT-6).

They

discovered that after bleomycine exposure at 370C, the cells
repaired potentially lethal damage and that hyperthermic
treatment at 43°C inhibited this repair.

Goss and Parson

(1977) studied the effect of melphalan and hyperthermia
on human melanomas and fibroblasts.

They found that sensi-

tivity to melphalan was usually accompanied by sensitivity
to heat and that the combined treatment was not only synergistic in most lines but increased the differential between
fibroblasts and melanoma cells.
Comparative studies on the effect of supranormal temperfttures on normal and transformed cells, in vitro, of
similar or identical origin have been carried out recently
by Kase and Hahn (1975) and Beppino et al. (1976).

The

results indicated that normal cells were more resistant to
supranormal temperatures than transformed cells, used in the
experimental models.

These results are in disagreement with

those of Burger and Fuhrman ( 1964).
2.

In Vivo Experiments
One of the oldest reports in the literature linking

hyperthermia and cancer is that of Buch (1866); he reported
the disappearance of a sarcoma of the face after the patient
developed high temperature during two attacks of erysipelas.
Bruns (1887) reported a similar case; this time in a patient

6

with multiple recurrent melanomas.

Coley (1893) studied the

effect of erysipelas on patients afflicted with sarcomas and
carcinomas.

He noticed that the curative effect of erysipe-

las was systemic rather than localized and attributed this
to the toxic products of the microorganism causing the
disease.

Coley suspected that the presence of strepto-

coccus induced the production of antibodies which eventually
destroyed "the parasite of cancer."

Westermark (1898)

reported remissions of malignancies in patients with inoperable carcinoma of the cervix after treatments with hot
water baths and local applications of heat.
Percy (1916) succeeded in alleviating the symptoms
and obtained a few remissions in patients suffering from
carcinomas of the uterus after treatmment with hyperthermia
in combination with surgery.

Many of the patients who

benefited from this treatment were in advanced stages of
the disease.
Overgard and ·akkels (1940) used mice to study the effect
of diathermy on Wood's sarcoma.

The temperatures used by

these investigators ranged from 42 to 46°C.

They reported

that in most cases healing of the affected.area took place
after tumor ulceration and breakdown.

In the majority of

the cases that failed to respond as above, at least a
transient effect on the tumor was observed.
damage to normal tissue.

There was no

The investigators also combined

x.ray and hyperthermic treatment in an effort to inhibit
tumor growth.

They succeeded in curing afflicted mice with

7

doses of hyperthermia and radiation which would have been
ineffective if given separately.
Johnson (1940) developed an efficient system for the use
of radio waves in the treatment of tumors and used it to
study the effect of hyperthermia on the Walker rat carcinoma
and the Jensen rat sarcoma.
Woodal et al. (1959) reported on the effect of hyperthermia on the chemotherapeutic properties of certain drugs
on external malignancies of the head and face.

They perfused

with prewarmed blood in order to raise the temperature of
the area under treatment.

The combined therapy succeeded

in ameliorating the pain in most instances and regression of
tumors was accomplished in half of the cases.
Crile (1961) combined hyperthermia with anticancer
drugs or radiation for treating some malignancies in mice.
He failed to enhance the effect of hyperthermia with the
drugs but was successful in destroying tumors when supranormal temperatures were combined with radiation; this last
modality was also used to treat various animals and humans
with some success.
Cavaliere et al. (1967) treated 22 patients afflicted
with cancer of the ·limbs with supranormal temperatures.
Positive results were obtained

i~

eight cases.

Heating the

tumors was accomplished by regional perfusion with prewarmed
blood.
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Characteristics of Normal and Transformed
Cells in Tissue Culture
1.

Normal cells
These cells have a diploid genome and can be propagated

in culture for only a finite period of time after which they
stop dividing and die (phase III of in vitro growth; Hayflick, 1966), as illustrated in Figure 1.

Another charac-

teristic of these cells, in culture, is that they orient
themselves with respect to each other and stop growing after
they reach a certain density (contact inhibition or density
dependent inhibition of growth).

They require a fairly high

inoculation density in order to grow and do not form tumors
when injected into immunologically suppressed mice.
2.

Transformed and

~alignant

Cells

These cells have an aneuploid genome and can be cultured,

1~

vitro, indefinitely (see Figure 1) .

.If supplied

with an adequate amount of nutrients, they will not stop
growing when in contact with other cells and will continue
to divide, piling up on each other.

Malignant as well as

transformed cells can grow in culture even when inoculated
at low densities.

They do not orient themselves with respect

to the other cells in the culture and can

~form

tumors when

injected into immunologically suppressed mice.
Purpose and Rationale of the Present

---fi1V-e-:S"tig-a1J.on-

The purpose of this work is to compare the effect of
hyperthermia alone and in conjunction with a drug on normal

Figure 1.

Diagramatic representation of the theory
of in vitro cell proliferation (Hayflick
and Moorhead, 1961).
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Figure 1
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and transformed human lung fibroblasts.
It has been found that the sensitivity of cells to
hyperthermia not only changes from one cell type to another
but also changes within a seemingly homogeneous population:
Selawry et al. (1957) showed that cells surviving hyperthermic treatment could become thermotolerant, and succeeded
in developing three different sublines with this characteristic.

The different response of cells of the same popula-

tion to supranormal temperatures could be due to adaptation,
cell cycle dependence, or as suggested by Selawry et al.,
due to mutations.
Bucciarite (1928) and Juul and Kemp (1933) conducted
experiments which led them to conclude that cells were more
sensitive to heat during mitosis than during the other
phases of the cell cycle.

It was also found by Makino and

Nahara (1953) that the greatest damage caused by hyperthermic
shock to cells was during metaphase.

The results of these

experiments were later confirmed by Sisken et al. (1965)
and Westra and Dewey (1971).

The other phases of the cell

cycle Gl,S and G2 plus prophase were found to be only moderately sensitive and anaphase seemed totally unaffected
(Sisken et al. 1965).
Thus if cells are more sensitive to supranormal temperatures in metaphase than in other phases of the cell cycle,
more actively proliferating cells should be more affected
if exposed to hyperthermic shock than cells in interphase.
If true, this would provide us with an acceptable explanation
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for the increased sensitivity of malignant cells to supranormal temperatures.

However, it has been shown by Beppino

et al. (1976) that some normal cells dividing at a faster
rate than their transformed counterparts were still more
resistant to hyperthermic treatment than the malignant cells.
In searching for a treatment which would favor the
survival of cells in resting, Go or Gl phase, we decided to
increase the number of transformed cells in the mitotic
state, with a drug, prior to the use of hyperthermia.
If the drug was administered in vivo it should stop
actively dividing cells in mitosis.

Although the clinical

effect would be systemic, hyperthermia could be applied on
a localized basis only.

The normal cells of tissues sur-

rounding a given tumor would be, for the most part, in a
contact-inhibited state and as far as an increase in the
mitotic index, they would be refractile to the action of the
drug.

The final result would be a tumor with a greater than

normal nmnber of cells in mitosis and a surrounding tissue
practically undisturbed, except in the case of tumors growing at the site of actively proliferating normal cells.

MATERIALS AND METHODS
The cells used'in these experiments were human embryonic
lung cells (WI-38 and WI-38 Simian virus 40 transformed
VA-l3/2RA), purchased from the American Type Culture Collection (Rockville, MD).
Origin of the Cells Used
l.

WI-38 Cells
These cells were originally cultured by Dr. L. Hay-

flick (1964) from a three-month old fetus following a surgical abortion.

He isolated the cells by tearing or mincing

the lung tissue in a petri dish containing Eagle's medium
and placing the fragments (l-4mm 3 ) in bottles with a surface
area o f 100 em 2
When growth was observed, the old medium
containing the fragments was removed, and replaced by fresh
nutrient medium.

Subculturing of the cells was made when

they reached confluency approximately after 10 days.

As

soon as the cells became confluent, they were put on a
strict schedule of subcultivation.

Hayflick preserved the
cells by freezing a suspension of l.5-2Xl0 6 cellsjml in a

medium containing 10% sterile glycerol.
dispensed as 2ml aliquots in 5ml ampules.

The suspension was
After sealing,

the ampules were kept at 5°C overnight and then placed in a
deep freeze at -70°C.
In our laboratory, the :frozen cells were reconstituted
13

14
by vigorously shaking the ampules in a 37°C water bath and
by transferring the thawed contents into a T-25 flask containing basal medium Eagle (BME) with 10% serum warmed up
to 37°C.

After 24 .hours, the fluid was removed from the

flask and replaced with fresh medium.

After the cells

reached a confluent state, the cultures were split in halves
and transferred to T-60 flasks.

This procedure was repeated

every four days.
2.

Transformed Cells (VA-13/2RA)
Girardi et al. (1966) transformed the WI-38 cells

during phase II of their in vitro life span by exposing them
to SV-40.

The onset of transformation was considered to be

the time of contact inhibition loss (see Figure 1).

These

cells were thawed in our laboratory in the same manner
described for WI-38 cells.
Drug Used in These Experiments
The drug used· in these experiments was vinblastine
sulfate, 1 formerly called vincaleukoblastine (VLB).

The

drug has been shown to be a mitotic poison with an action
similar to that of vincristine, colchicine and colcemide.
Biopsided non-responsive tumors, from patients treated with
VLB, still show large numbers of cells in metaphase.

This

seems to indicate that metaphase arrest is not the only
way in which VLB inhibits tumor growth.

There is some

1 Grand Island Biological Co.; Grand Island, N.Y.
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evidence pointing to an antimetabolic activity:

the drug

seems to interfere with the pathway of aminoacids leading
from glutamic acid to the citric acid cycle and to urea.
Routine Stock Maintenance
The two cell types used in these experiments were
propagated in BME 90%, and 10% fetal calf serum (complete
medium), micoplasma tested and virus screened.
was sterilized by using a filter, pore size

The media
and

0.22~m,

was stored at 3°C; the sera was stored in volumes of 3 to
7 ml. at -4 0 C.

One hundred units of penicillin and

lOO~gjml

of streptomycin were added to each container of medium
before use.

WI-38 cell populations were split in a 1 to 2

ratio every four days with no intervening feedings.

This

was accomplished by removing the used medium and rinsing the
confluent cell layer 2 times with Ca-Mg- free phosphate
buffer saline (CMF-PBS) prewarmed at 37°C.

The first rinse

was removed after five minutes and the second after approximately 30 seconds.

Three ml of trypsin were added to the

flasks to be subcultured; the trypsin used was Difco 1:250
and was prepared as a stock solution 4X strength.
filtered through an 0.22

~m

millipore

test tubes in 5-7 rnl aliquots, at 4°C.

filt~r

2

It was

and stored in

The trypsin solution

was allowed to act on the cells for one minute and then it
was removed; residual trypsin was allowed to work for an
additional 3-·9 minutes before 10 ml of medium (prewarmed at
2Difco Laboratories Incorporated; Detroit, Michigan.
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37°C) were added to the flasks in order to rinse the partially detached cells.

This process was repeated twice,

and then, by means of a pipette, the cells were forced up
and down against the walls of the container until they were
dispersed.

Five ml of this suspension were delivered into

a second flask; then the total volume, for each flask, was
brought to 10 ml by adding 4 ml of medium and 1 ml of serum,
prewarmed at 37°C.

The inoculated flasks were gassed with

air containing 5% C0 2 filtered through glass wool. The
cells were then incubated at 37°C. The stock cells were
propagated in T-60 pyrex flasks.
An almost identical method was used in the cultivation
of the VA-13/2RA cells, the only difference being that the
dispersion was accomplished in only 9 ml of medium and 1. 5-2 ml
of this suspension were used to seed other T-60 flasks; the
final volume was 10 ml.

These cells were subjected to a

total medium exchange 3 days after inoculation and were
subcultured every five days.
Proce~ure

Used for Studying Acute

~.!._ortali ty

In these studies WI-38 and VA-13/2RA qells in log phase
were exposed to hyperthermia.

Two of the T-60 flask cultures

were suspended, after trypsinization, in complete medium
3
in the volumes required to obtain a 5.56-9.58X 10 cellsjml.
The cells were counted by using a Coulter counter model B.
Eighteen Carrel flasks (or more) were inoculated with
a Cornwell syringe (one ml of cell suspension .in each flask).
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The flasks containing the WI-38 cells were subjected to
hyperthermic treatment after three days of incubation at
0

37 C, by immersing them in a water bath to raise the ternperature of the cells.

Previous to immersion in the water

bath, the medium was removed and replaced with Hank's
balanced salt solution.

The temperature was controlled to

~ 0.2°C with a water thermostat.

Three flasks at a time

were removed at random from the water bath at the intervals
indicated in the results and the cells were stained with
0.05 ml of 0.4% erythrosin B solution for each ml 'of cell
suspension (Phillips and Terryberry., 1957).
were then incubated for 5 minutes at 37°C.

The flasks
The cells were

counted under a green filter using a phase contrast Nikon
model M microscope.

The counts were made by moving the

flasks at random and counting the cells in the area marked
on the ocular; 100 or more cells were counted from each of
the three flasks.

Unstained cells were considered living,

while stained cells were considered dead.

The percent

survival was calculated as shown in the results.

VA-13/2RA

cells were treated exactly as the WI-38 cells except that
hyperthermic treatment was given 24 hours after inoculation.
Because the cells were heated in Hank's balanced salt solution a control experiment was run to control the tolerance
of the cells to it when incubated at 37°C for different
lengths of time.
Each experiment was run at least twice; three flasks
were used in order to determine the percent survival after
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after exposure.

The second test 1 run for the purpose of

checking on the reproducibility of the results was also
designed to add or complement the first test.

All readings

were considered in the final average obtained unless statistically proven to be an aberrant extreme value (see
graph in Figures 3 1 4 or Tables V and VI in the Appendix).
Determination of the Drug Concentration
to be Used in These Experiments
The concentration of VLB to be used in the treatment
of the cells in these experiments was determined by exposing
the transformed cells to different concentrations of the
drug for different lengths of time and determining the percenta.ge of mitoses.

Cells were considered in mitosis when

they adopted the characteristic round shape of cells undergoing division.

Over 100 cells were counted from each one

of a duplicate set of flasks and the whole test was run
twice.

The concentration of the drug to be used in this

experiment was determined by observing the increased number
of mitoses and the cyto-toxicity caused by the different
concentrations (see Table 1 in Appendix).
Procedure Used for Studying the
Delayed Effect of Hyperthermia
and/or VLB
1.

In these studies WI-38 and VA-13/2RA cells growing

logarithmically were treated.

The effect of hyperthermia

and the drug was assessed by measuring growth after exposure
of the cells to the selected treatments.
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The results were expressed as percent growth as compared to the untreated controls.
were assigned a 100% growth value.

The untreated controls
Four replicate cultures

in T-60 flasks containing transformed cells in log phase
(24 hours after inoculation) and four replicate cultures of
normal cells growing logarithmically (72 hours after inoculation), were used for this part of the experiment.

The

medium was removed from all four flasks and replaced with
10 ml of complete medium in the two control flasks and by
medium plus O.lvg of VLB/ml in the other two.

The desired

concentration of the drug was obtained by serial dilutions
of the original solution.

The four T-60 flasks were incu-

bated for an additional 24 hours at 37°C.

At the end of

this period the medium was carefully removed with a 10 ml
pipette and was centrifuged at 1000 rpm for 5 minutes.

In

the meantime, 5 ml of CMF-PBS were added to each one of the
flasks from which the medium was removed.

The cell free

supernatant was discarded and the 5 ml of CMF-PBS were
removed from the T-60 flasks and were used to resuspend the
cells in the centtifuge tubes (mostly detached and in
mitoses).

The suspension was centrifuged

~gain,

the cells

resuspended in 3 ml CMF-PBS and put into the original flasks.
One ml. of trypsin was added to each one of the T-60 flasks.
Immediately after they were incubated for 5-10 minutes at
room temperature, the cells were dispersed and transferred
to a centrifuge tube containing 4 ml of CMF-PBS.

The cell

suspension was centrifuged, the supernatant discarded and
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the cells resuspended in 10 ml of medium.

Immediately

after suspension was accomplished, the medium containing
cells was transferred to the corresponding flasks and was
used to suspend the cells which still remained attached.
This procedure was designed to minimize cell loss, and was
particularly important in the case of the two flasks treated
with VLB, since this drug blocks mitosis at metaphase.

Cells

in metaphase often detach from the glass surface and float
about in the medium.

Had the old medium been discarded (as

is done when cells are routinely sub-cultured) many metaphase
cells would have been lost, thus altering the final results
(see Table 1).
The four T-60 flasks that were used in each experiment
were obtained from a single 5-day culture or two 4-day cultures for the VA-13/2RA and WI-38 cells, respectively.

The

flasks were trypsinized and the cell number adjusted to
5.4-7.0 X 10 3 cellsjml for the transformed line and between
5.8-6.7 X 10 3 cell'sjml for the normal strain, previous to
inoculation into the four replicate T-60 flasks.

Inocula-

tion was accomplished by means of a 10 ml Cornwell syringe,
All cell counts were made with a Coulter counter.
suspensions were pooled into two groups:

The cell

A) in which the

contents of the two flasks were untreated, and B) in which
the contents of the two remaining flasks
VLB.

~~re

The pooled suspension of A and B were

treated with

transfe~red

to

two 100 ml Erlenmayer flasks (contents of A and B were kept
separate).

Replicate T-15 flasks were prepared by inoculating
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the contents of flasks A and B into two separate groups by
means of a 2 ml Cornwell syringe.

The replicate T-15

flasks were gassed (air 95% + co 2 5%) and incubated for
15 minutes at 37°C. Each test was run at least twice and
2 or 3 flasks were used for each data point.

It was experi-

mentally demonstrated that 43°C for 1/2 hour was a suitable
temperature and length of exposure for the purposes of
this experiment.

Some flasks were exposed to 40°C for 14

hours.
After incubation of the replicate cultures for 15 minutes at 37°C, the flasks to be treated were immersed in a
water bath at 43°C for 1/2 hour.

At the end of the treat-

ment they were taken out as quickly as possible and the
flasks to be exposed to a second temperature (40°C for 14
hours) were re-immersed immediately after the temperature
was lowered.

Lowering of the temperature was accomplished

by adding ice cold water to the bath.

The desired tempera-

ture was attained ·in less than 5 minutes.

The remaining

flasks were put in the incubator at 37°C.
All flasks were trypsinized three days after the beginning of the hyperthermic treatment and the cells were counted
in the electronic counter.
2.

In these studies confluent WI-38 and three days VA-13/2RA

cells were treated.

This part of the experiment was basically

very similar to that previously described.

The density of

the cells inoculated in the four replicate flasks at the

Table I.

Diagram of the procedures used to test the
delayed effect of supranorma1 temperatures,
and or vinblastine sulfate, on normal and
transformed cells.
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Table 1

VA-l3/2RA Third Day Growth
WI-38 Confluent Cells

VA-13 Log Growing
WI-38 Log Growing

Equal number of cells inoculated into T-60 flasks

Equal number of cells inoculated into T-60 flasks

Control Flasks

Control Flasks

Test Flasks

'

'

Test Flasks

' '

Cells inoculated

Cells inoculated
WI-38 in log phase
VA-13/2RA in log phase

Media change

New Media

1
l

48 hours
Exposure

rg

New media

.,d

48 hours

Exprr·

Cells suspended and centrifuged to rescue floaters
(see text).
Cells inoculated into T-15

J

fla1
I

dr]

New Media

New media
and

1
Expire
24 hours

24 hours
Exposure

l

Cells suspended and centrifuged to rescue floaters
(see text). Cells inocu-

lat:r into

T[1s

flask];

1·

Cells inoculated for 15
Minltes at 37fC

inoculated for 15
MinuJes at 37oc

Cells were subject to hyperthermic treatrents (except
controls)

Cells were slbject to hyperthermic treatments (except
controls)

l

~
t
Cells were counted 4 days

after hyperthermic treatments.
r

Cell~

l

J

Cel~
were c unted 4 days
after hyperthermia treatment
r
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beginning of the experiment, ranged between 1.0-1.2 x 10 5
cellsfml in the case of the WI-38 cells and between 8.0-9.0
4
X 10 in the case of the VA-13/2RA cells. The VLB treatments (same concentration as in the previous experiments)
were given on day 3 and 4 to the transformed and normal
cells respectively; the exposure time was 48 hours.

The

medium containing the drug and some floating cells was
removed and centrifuged in order to rescue the floaters.
The procedures leading to the inoculation of the replicate
T-15 flasks were almost identical with those of the previous
experiment:

the exception being that of the solution made

previous to the plateing of the replicate culture flasks.
In this experiment the treated cells in the T-60 flasks
were confluent and very numerous:

low inoculations were

required at the beginning of the experiment to allow enough
space for the cells to grow.

For this reason their content

was diluted 1:6 and 1:4, for the VA-13/2RA and WI-38 cells
respectively, just prior to seeding (see Table 1).
Quantification of Results
The cells in 2 or 3 flasks were counted for each one
of the treatments in this experiment.

The·contents of each

T-15 flask were suspended in 1 ml of trypsin and were added
to 9 ml of counting solution (0.9% NaCl and 0.01% sodium
azide).

Four to 6 readings were made for each flask.

The

counts were averaged and the percent growth was obtained
from this value.

The mean of the readings obtained for the
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control group was considered to be 100% growth.

Since

each experiment was done at least twice, 4 or more readings
were made (as a percent value).

The average of all these

counts was considered to be the final result for each
different treatment.

If extreme .values were observed, they

were subjected to statistical tests for extreme values at a
probability level of 0.05; the value was discarded only if
the results exceeded the 95% confidence limit (Bliss and
Calhoun, 1954).

RESULTS
Assessment of the Percent Survival
with a Vital Stain
Cell counts, in this part of the experiment, were made
within the flasks without the need of trypsinization.

This

precaution was taken to avoid subjecting the cells to a
variable other than the hyperthermic treatment.

This tech-

nique was a modification of the staining procedure used by
Phillips and Terryberry (1957).

It was for this reason that

an experimental control was used to see whether or not long
exposures of these cells to HBSS would have any detrimental
effect on their survival.

Tables 2 and 3 (see Appendix)

show that even after exposures of 16 hours, more than 90%
of the cells remained alive.
Growth Characteristics of WI-38
and VA-i3/2RA Cells
The graph in Figure 2 compares the growth of both WI-38
and VA-13/2RA cells.

WI-38 cells pass through a lag phase

prior to entering the logarithmic phase of growth.

It was

observed, in preliminary experiments, that when the drug
was added during the lag phase, many cells died:

adding

the drug at this time was putting too much strain on cells
trying to regain their vigor after subcultivation.

Because

of this, it was decided to treat the cells on day 3 after
inoculation.

The VA-13/2RA cells, on the other hand, were

more resistant:

they attached and began to divide readily.
27
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No enhancement of drug-induced damage was observed when the
cells were exposed to VLB 24 hours after seeding.

Since

these cells grow so fast, and their survival had to be
assessed optically, the count had to be done before the
cell population became too dense.
Another characteristic of the growth curves is that
VA-13/2RA cells continue to grow at a higher rate than WI-38
cells, which reach a plateau or a confluent state after
75 hours.
Drug Sensitivity of the Transformed Cells
Table 1 (Appendix) shows the response of the cells
(VA-13/2RA) to different concentrations of the drug and to
different times of exposure.

Concentrations higher than

0. 1 pg/ml proved to be too toxic for the purposes of this
experiment.

Toxicity was apparent in the form of granula-

tions, dented margins, lysed cells and bleb formation.
Although some degree of toxicity was observed at 0.1 pgjml,
it was considered acceptable on the basis of evidence
gathered from microscopic observations.

Cells continued to

divide and maintained most of their healthy characteristics
such as shape, attachment, growth, etc.
After 24 hours of exposure to the drug (0.1 vgfml), a
marked increase in the mitotic index of the cell population
could be observed.

The mitotic block seemed to decrease

somewhat after 48 hours.
for 0.01 and 0.001 pgjml.

A similar situation seems to occur

Figure 2.

Growth curve:

normal and transformed

human lung fibroblasts (WI-38 and

VA-13/2 RA).
The vertical bars in this and the other
graphs show the spread of the readings
used to obtain the average values.
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Immediate Cell Mortality Induced
by Hyperthermia
Comparison of the percent survival of WI-38 and VA-13/2RA
cells reveals a marked difference in the response of these
cells to hyperthermic shock (Table 5 in Appendix).

Between

2 and 5 hours appear to be the exposure time at which the
transformed cells begin to show a marked diminution in survival at 44°C (Figure 3)~

A similar decrease in survival,

at this temperature, was observed for normal cells between
the fifth and the sixth hour of exposure.

After 9-1/2 hours

the number of WI-38 cells surviving, ranges between 50 and
80%, whereas for the same time and exposure, the VA-13/2RA
cells surviving, range between 10 and 30%.
Table 5 (Appendix) and the graph in Figure 4 show the
differential response of the cellular system exposed to
46°C.

The transformed cells show the detrimental effect

of supranormal temperatures soon after one hour of exposure.
WI-38 cells begin to show a similar effect only after 2 hours
of exposure.

The detrimental effect is, however, less

marked than in the previous case.

After 5 hours of hyper-

thermia, less than 10% of the transformed cells still
remained alive compared to 40 and 60% of the WI-38 cells.
Delayed Damage to Cells Induced
by Hyperthermia and VLB
In Table 7 (see Appendix) and Figure 5, the differential
response of the normal and transformed cells to hyperthermia
can be observed.

In this particular instance, the response

Figure 3.

Percent survival of normal and transformed
cells after hyperthermic treatment (44°C)
for different lengths of time.
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Figure 4.

Percent survival of normal and transformed
cells after hyperthermic treatment (46°C)
for different lengths of time.
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Figure 5.

Delayed effect of hyperthermia andjor
vinblastine sulfate on normal and transformed human lung fibroblasts.

FIGURE 5
Trt~~tmcmt

VA-13

log,

Ph~se

WI-38

Growth

lo~.

phase growth

I

Control 100:€

l
!

!

44~

0

79%

4;· C 30 :t1nutes

0

I;.J C JO minutes

15%

10%

0

40 C 14 nours

0

80'(

;

z~

40 C 14 hours

..

VLB 24 hours

VL.B
0

56~.·

24 hours

38~

J?%

28.5%

43 C )0 m1nuces
VLB

'

24 h!>urs

c

4) C 30 minutes

7~

12,%

14~

24~

0

liO C l~ nou.rs

vr.a
0

I

2/f nours

40 C 14

""

'I

~ours
(

4

inoculation. Exposure lasted

24 hours and trowth was assessed

4

days attar treatment.

The drug was added 3 days atter
inoculation. Exposure lasted

. 24 hours and rrowth was
assessed 4.days attar treatment

t:-

FIGL~

5 (cont•d)

Treat111ant
VA-l) Th1~d Day ~rowth

I

'Control

lCO~

WI-36 Confluent

II
;

1'control 100$

I
j

I

0

77f.

aJ C 30 m1nutes 146% .

0

43

0

c

30 m1nutes

1 22,%

21%

41~

66.%

1531

401

.tro c 14 hours

0
ItO C l4 hours

VL3 aS hours

VLB 46 'lours

0

I

35.%

)2~

43 C 30 m1nutes
VL3 48

hours

0

IIJ C 30 m1nutes

·I

lOf,

14,%

14%

29%.

0

40 C 14 nours
VLB
0

48 hours

40 C 14 hours

l
The drug was added 72 hours after
inoculation. Exposure laRted 48
hours and gro~~h was aaseRsed.
4 days aft~r treatment

I

.,

"'
00

The drug was added 96 hours
after inoculation (ce11s confluent).
Exposure lasted 48 hours and growth
was asResRed 4 days after treatment.

39

was measured as percent growth 4 days after the treatments
had been completed.

This was done in order to take into

account the delayed effect of heat upon the cells.

A comparison is made of the growth response of both
types of cells in two different stages of their life in
vitro:

log and confluent WI-38 and log and third day growth

VA-13/2RA cells.

The results show that the transformed

cells respond similarly when exposed to 43°C for 1/2 hour,
24 or 72 hours after they had been inoculated.

The same

holds true for the WI-38 cells that were in log phase of
growth or in a confluent state before exposure.

Also,

the VA-13/2RA cells showed less growth, under the same
treatments, than the normal cells.

DISCUSSION
The experimental results reported here support the findings of several investigators who found that in general,
cells derived from tumors and transformed cultured cells are
more sensitive to hyperthermia than normal cells in vitro.
Beppino et al'(l976) made a comparison of the effects
of hyperthermia on normal and malignant cells in vitro.
They compared the sensitivity of several normal cell types
with that of their transformed equivalents.
and design were similar to those we used.

Their methods
From our results,

summartzed in Figure 3 (exposure to 44°C and Figure 4 (exposure to 46°C), it can be concluded that cell mortality
is proportional to the increase in temperature and length
of exposure.

Beppino et al obtained similar results with

cells at 42.5-43 0 C.
As seen in Figure 5, the transformed cells in the log
phase that were exposed to 43°C for 30 minutes and th~n
incubated at 37°C (for 4 days) showed only a 44% growth as
compared to that of the controls.
phase WI-38 cells
trols.

show~d

Identically treated log

79% growth as compared to the con-

A similar result was

obs~rved

in the experiment
'

corresponding to the 3-day growth of VA-13/2RA and confluent
WI-38 cells; the values were 46 and 77%, respectively.
These results confirm the conclusion reached in the acute
mortality studies and are in agreement with those found by
40
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Kase and Hahn (1975) who used a completely different experimental design.

It seems safe to conclude, therefore, that

the virus-transformed WI-38 cells are intrinsically more
sensitive to hyperthermia than the normal WI-38 cells.

The

above conclusion applies to acute mortality and to delayed
effects of supranormal temperatures, in the experimental
model used.
When low grade (40°C) hyperthermic treatment is used
as it was by Giovanella et al. ( 1970) for leukemic cells
(L-1210) in vitro, we found that after 14 hours exposure,
there was a significant decrease in the survival of the
transformed cells.

The growth of the transformed cells,

in log phase, was found to be 26% of the control, substantially less than that obtained for the WI-38 cells under
identical experimental conditions (80%).

The results ob-

tained for the three day growth of transformed and confluent
normal cells in this same phase of the experiment were
similar, but somewhat less pronounced (41% for the transformed cells and 86% for the normal).

Under the experimental

conditions followed in ':t.his laboratory this particular treatment was by far the most effective in producing results
that favored the survival of normal cells.

A statistical

analysis of the results reveals a significant difference
between the two groups (0.05 level of confidence) for the
three day growth of VA-13/2RA and confluent WI-38 cells, and
a highly significant difference (0.01 level of significance)
for the log phase WI-38 and VA-13 cells.
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When the results of the log phase cells are compared
with those of the confluent or three day growth cells, for
each treatment, a close correspondence can be seen.

The

differences, except for one exposure, were almost the same.
When the cells were treated only with VLB, during the log
phase of growth, a significantly different and unexpected
result was obtained.

The transformed VA-13 cells were more

resistant to the toxic effects of VLB than the normal WI-38
cells ..
Johnson et al. (1960) suggested that the oncolytic
effect of the drug was due to its interference with the metabolic pathway leading from glutamic acid to urea and from
glutamic acid to the citric acid cycle.

Vaikenicius et al.

(1972) made cytologic observations of responsive and nonresponsive tumors and could not predict the outcome of the
treatment just by observing the relative number of mitoses
in the tissues studied.

However, they noticed in some of

the regressions a considerable amount of hemorrhaging similar to that described for tumors regressing after colchicine
treatment.

It is our opinion that even if tumor cells are

not seriously affected by VLB, regression of the malignancy
could occur as the ·result of the effect of the drug on the
cells taking part in the process bf vascularization of the
tumors.

Normal vascular cells would be the target of the

drug, and in some instances, the cause of the regression.
When the 3-day growth transformed cells are compared,
for their response to VLB, against the confluent WI-38 cells,
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no significant difference is found.

These results suggest

a decreased sensitivity of the normal cells to the drug,
when confluent.
The results in Fig. 5 suggest that the expected
increased ratio of normal to transformed cells, when the
treatment was VLB plus hyperthermia, did not occur.

These

results seem to indicate·that the cells used in this experiment are not more sensitive to hyperthermia, during mitosis,
as was true for the cells studied by Bucciante (1928), Juul
and Kemp (1933), Makino and Nahara (1953) and others.

Pos-

sibly the benefits obtained by the mitotically less active
normal cells, when subject to hyperthermia, were cancelled
out by its higher sensitivity to the effect of the drug,
as suggested by the results in Figure 5.
Possible Mechanisms of Hyperthermic Damage
Supranormal temperatures may affect the activity of
enzymes according to their susceptibility to alteration.
Enzyme denaturation due to supranormal temperatures is one
of the possible causes of cell damage (Giese, 1973).

Giese

noted that DNA is not affected in this respect by temperatures below 70°C and, consequently, it should be overlooked
as a cause of cell damage at the temperatures used in this
research.

RNA seems to be the most likely of the macro-

molecules to be damaged by hyperthermia.

When the ribosomes

of the thermophile Bacillus stearothermophilus were compared
with those of the mesophile E. Co_li, for heat sensitivity,
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it was found that the ribosomes of

~·

Stearothermophilus

were more resistant than those of E. Coli.

Tests showed

that the protein moiety of the ribosomes that were heat
resistant was as heat labile as that of the ribosomes from
E. Coli.

It has been found that the polyamines from the

thermophile did not protect the ribosomes of the mesophile
from high temperatures.

Ribosomal RNA from E. Coli begins

to show some instability at about 43°C whereas that of B.
Stearothermophilus is still stable up to about 65 to 70°C.
(Mangiotini et al. 1965).
The decrease in the rate of amino acid' incorporation
noticed in several investigations has been traced to

poly~

ribosome disaggregation (McCormick and Penman, 1969); the
damage incurred by these aggregates was not irreversible
at •12°C in Hela cells.

Normalization of protein synthesis

was restored by re-incubation of the treated cells at 37°C
and only partially restored when they were maintained at
42°C for more than 10 minutes.

Recovery at 42 0 C was shown

to be dependent on RNA synthesis.

McCormick and Penman

has postulated that a particular type of RNA, sensitive to
hyperthermia, is synthesized by the cells in response to
depressed protein syntehsis.

This RNA would promote the

association of ribosomes into polyribosomes and would be
part of the normal mechanism of the cells for the regulation
of protein translation.
Inhibition of protein synthesis in Hela cells by the
drug actidione was shown to protect cells against polyribosome
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disaggregation.

Cells were not protected when DNA dependent

RNA synthesis was blocked with actinomycin D.

Further evi-

dence pointing towards a heat labile RNA species is provided
by reticulocytes; cells in which RNA synthesis is no longer
possible.

When these cells are subject to hyperthermic

shock, protein synthesis is inhibited and recovery never
occurs

(Fuh~

1974).

There is still another important cell

component which might be involved in heat induced damage;
there is some evidence pointing to cell membrane disruption
as the cause of cell death.

The stored lipids of animals

adapted to high temperatures have a higher melting point
than those of the non--adapted controls.

The drug adriamycin

enters into Chinese hamster cells (HAI) much more easily at
43 than at 47°C indicating a heat induced modification in
the permeability of the cell membrane (Hahn

~ ~1.

, 1975).

Possibilities of Hyperthermia for
the Treatment of Cancer
A general picture of the positive and negative aspects

of the use of hyperthermia as a tool for the treatment of
some types of cancers is beginning to emerge:

Selawry et al

(1957) and McCormick and Penman (1969) warn against the possibility of creating temperature resistant tumors after
failing to completely destroy the malignancies with the
first treatments.

We have also learned that tumors will

heat up more easily than the surrounding tissues (Leevine
et al., 1976) and that hyperthermic treatments can be useful
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in combination with radiation (Overgard and Okkels, 1940;
Hoeffer et al., 1976).

We have also mentioned that supra-

normal temperatures in combination with drugs can be

used~

successfully, for the treatment of some malignancies.

Har-

ris (1976) warns against a possible decrease in the activity
of the Cytotoxic T-lymphocytes after exposure to supranormal
temperatures.
One of the results of our research suggests a new
mechanism for the therapeutical activity of VLB on tumors.
Tumors heat up easier than normal tissues by virtue of their
inefficient blood flow.

If VLB impairs the vascular supply

to the neoplasm even more, the hyperthermic damage would
increase.
Based on available data, it is safe to assume that
the clinical use of hyperthermia, alone or in combination
with drugs, x-rays, surgery and immuno therapy will be
effective for the treatment of some malignancies.

SUMMARY
1.

The effect of supranormal temperature and vinblastine
sulfate on normal WI-38 and transformed VA-13/2RA cells
has been investigated.

2.

It was found that the transformed cells were more sensitive to supranormal temperature, both in their immediate and delayed response.

3.

Vinblastine sulfate impaired the growth of normal cells
more than that of malignant cells when they were both
growing.logarithmically.

4.

The combination of vinblastine sulfate plus hyperthermia
did not produce an increased ratio of surviving normal
versus transformed cells.

5.

The highest normal/transformed ratio, for the cellular
0

system used, was found to be 40 C for 14 hours.
6.

It is possible that tumor regression after vinblastine
treatment might be, in some cases, due to the action of
the drug on the host 1 s vascular tissue.

Impairment of

vascular tissue growth would affect the development of
tumors.
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Table I
The Effect of Vinblastine Sulfate on the Percentage of
Mitoses in a VA-13/2RA Cell Culture

Exposure Time in Hours
24

28

72

Percent of Cells in
Mitosis
Control Test:

Run Number l

6.9

6.0

6.3

Control Test:

Ruri Number 2

3.3

4.5

4,5

0.1

39.0

29.8

20.8

0.01

34.0

30,4

18.0

0.001

21.8

13.7

13.1

0.001

25.8

14.0

20.2

0.0001

8.4

10.5

7.0

0.0001

5.0

10.0

11.9

Vinblastine Treatments
ln " f.lg/m~
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Table II
Tolerance of VA-13/2RA Cells to
Hank's Balanced Salt Solution

Exposure Time in Hours

Flask N°

1

2

3

Average

Pe.rcent Survival

0

98

96

95

96

1

97

97

97

97

2

98

92

90

93

4

98

97

90

95

6

95

93

93

94

16

94

93

92

93

--Percent survival - (Surviving cells/number of cells counted)
X ( 100).
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Table III
Tolerance of WI-38 Cells to Hank's
Balanced Salt Solution

Flask N°
Exposure Time in
Hours and Minutes

1

2

3

Average

Percent Survival

0
0

98
99

99
100

100
97

99

1

94

100

94

96

2

98

97

97

97

3
3

98
98

99
95

98
100

98

6:35

98

98

98

98

7

96

98

95

96

9:40

96

95

98

96

10

97

98

98

98

21

99

97

92

96
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Table IV
Growth Curve of VA-13/2RA
and WI-38 Cells

Time In Hours

Cell number X 10
VA-13/2RA Cells

0

52.6

48

123.2

74

183.6

95.5

274.8

120

297.2

142

328.4

165

341.6
WI-38 Cells 17th Passage

0

65.7

34

61.6

76

184.2

130

197.6

178

215.6

WI-38 Cells 27th Passage
0

52.0

48.5

47.3

71.5

88.4

105.5

130.7

119.5

137.2

2
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Table V
Tolerance of WI-38 and VA-13/2RA
Cells to 44°C

Hours and Minutes
of Exposure

Percent Survival*
WI-38 Cells

1

1

97.1

2

96.3

5

1
1
2
2

5:30

1

93.1

6

2

97.1

7

1

78.5

7:10
8:10

2
2

81.9

9:30

1

88.6
70.1

9:30

2

59.0

3

98.4
99.7

97.1

VA-13/2RA Cells
1

1

94.2

2

1

93.0

3

1

83.4
91.4

6:45

2
2
2
1

7

2

37.1

8

2

14.4

9

2

12.3

9:45

1

21.9

4
5

89.4

79.3
67.6

*Survival was measured immediately after exposure.
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Table VI
Tolerance of WI-38 and VA-13/2RA
Cells to 46°C

Hours and Minutes
of Exposure

Percent Survival*
WI-38 Cells

0:15
1

2

1
1
1

4
5

98.6
97.3

1

94.6
82.0

2

83.6

2
3

99.3

1
2
1
2

76.5

69.3
38.5
56.5

VA-13/2RA Cells
1

2
3

4
5

1

95.5

2

97.1

1
2
1

80.5

43.1

2

24.2

1
2
1

14.0

2

5.4

71.4

12.4
4.3

*Survival was measured immediately after exposure.
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Table VII
Delayed Response of Logarithmically Growing WI-38
and VA-13/2RA Cells to Hyperthermia and'VLB

Treatment

Percent Growth

Average

WI-38
A.

43°C for 1/2
Hour

83
75
67
92

79·

B.

43°C for 1/2
Hour and 400C
for 14 Hours

22
13
13
10

15

c.

40°C for 14
Hours

86
72
79
82

80

D.

VLB for
24 Hours

33
40
37
40

38

E.

VLB for 24 Hours
43oc for 1/2 Hour

24
30
30
30

28.5

F.

VLB for 24 Hours
43oc for 1/2 Hour
400C for 14 Hours

8
15
14

12

G.

VLB for 24 Hours
40°C for 14 Hours

35
21
22
10

22

VA-13/2RA
A.

43°C for 1/2
Hour

(eontinued)

35
42
47
40
57

44
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Table VII.

(continued)

Treatment

Percent Growth

Average

(VA-13/2RA)
B.

43°C for 1/2
Hour and 400C
for 14 Hours

10
11
10

10.3

c.

40°C for 14
Hours

21
24
22
37

26

D.

VLB for
24 Hours

64
58
49

D.

VLB for
24 Hours

57
57
62
44

56

E.

VLB for 24 Hours
43°C :L'or 1/2 Hour

45
49
40
47
21
28
29

37

F.

VLB for 24 Hours
43°C for 1/2 hour
4ooc for 14 Hours

G.

VLB for 24 Hours
400C for 14 Hours

7.9
8.0
6.0
7.0
10
11
10

7

10
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Table VIII
Delayed Response of Confluent WI-38 and Third Day
Growth VA-13/2RA Cells to Hyperthermia
and VLB
Treatment

Percent Growth

Average

WI-38
A.

43°C for 1/2
Hour

86
66
89
77
66

77"

B.

43°C for 1/2
Hour and 4ooc
for 14 Hours

25
19
20
17
22
21

21

c.

40°C for 14
Hours

82
105
90
70
84

86

D.

VLB for
48 Hours

52
51
50
28
23
35

40

E.

VLB for 48 Hours
43°C for 1/2 Hour

30
25
28
43
40
45

35

F.

VLB for 48 Hours
430C for 1/2 Hour
4ooc for 14 Hours

21
20
15
9
10

14

7

(continued)
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Table VIII.

(continued)

Treatment
G.

VLB for 48 Hours
40°C for 14 Hours

Percent Growth
26
25
24
41
29

Average
29

VA-13/2RA
A.

43°C for 1/2
Hour

46
58
49
40
43

A.

43°C for 1/2
Hour

40
48
49
39

46

B.

43°C for 1;'2
Hour and 4ooc
for 14 Hours

31
28
30
16
15
21
15

22

c.

40°C for 14
Hours

36
42
51
49
51
36
39
30
32

41

D.

VLB for
48 Hours

65
58
53
47
41

53

(continued)
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Table VIII.

(continued

Treatment

Percent Growth

Average

E.

VLB for 48 Hours
43oc for 1/2 Hour

40
38
31
28
28
26

32

F.

VLB for 48 Hours
43oc for 1/2 Hour
4ooc for 14 Hours

15
16
10

10

9

5
6
10
11
12

G.

VLB for 48 Hours
4ooc for 14 Hours

65
58
53
47
41

53

